Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and Outcomes

World Journal of Surgery

Volumn 34, Issue 6, 2010, Pages 1222-1231

  Sugitani, Iwao ^a   Toda, Kazuhisa ^a   Yamada, Keiko ^a   Yamamoto, Noriko ^a   Ikenaga, Motoko ^a   Fujimoto, Yoshihide ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; ECHOGRAPHY; FEMALE; HUMAN; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; OBSERVATION; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; THYROID TUMOR; THYROIDECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; OBSERVATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 77955557317     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0359-x     Document Type: Article

References (44)

1. Hedinger CE, Williams ED, Sobin LH (1988) Histological typing of thyroid tumours. The WHO international histological classification of tumours, 2nd edn. Springer-Verlag, Berlin
2. Takahashi S (1969) Clinicopathological studies of latent carcinoma of the thyroid [in Japanese]. Nippon Naibunpi Gakkai Zasshi (Folia Endocrinol Japon) 45:65-79
3. Sampson RJ, Key CR, Buncher CR et al (1970) Papillary carcinoma of the thyroid gland: sizes of 525 tumors found at autopsy in Hiroshima and Nagasaki. Cancer 25:1391-1393
4. Sampson RJ, Woolner LB, Bahn RC et al (1974) Occult thyroid carcinoma in Olmsted country, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 34:2072-2076
5. Fukunaga FH, Yatani R (1975) Geographic pathology of occult thyroid carcinomas. Cancer 36:1095-1099
6. Bondeson L, Ljungberg O (1981) Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer 47:319-323
7. Olen E, Klinck GH (1966) Hyperthyroidism and thyroid cancer. Arch Pathol 81:531-535
8. Carlini M, Giovannini C, Mercadante E et al (2006) Incidental thyroid microcarcinoma in benign thyroid disease: incidence in a total of 100 consecutive thyroidectomies [in Italian]. Chir Ital 58:441-447
9. Noguchi S, Yamashita H, Uchino S et al (2008) Papillary microcarcinoma. World J Surg 32:747-753
10. Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980-988
11. Allo MD, Christianson W, Koivunen D (1988) Not all "occult" papillary carcinomas are "minimal". Surgery 104:971-976
12. Sanders LE, Rossi RL (1995) Occult well differentiated thyroid carcinoma presenting as cervical node disease. World J Surg 19:642-647
13. Sugitani I, Yanagisawa A, Shimizu A et al (1998) Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 22:731-737
14. Cobin RH, Gharib H, Bergman DA et al (2001) AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7:202-220
15. AACE/AME Task Force on Thyroid Nodules (2006) American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63-102
16. British Thyroid Association, Royal College of Physicians (2007) Guidelines for the management of thyroid cancer, 2nd edn. http://www.british- thyroid-association.org/news/Docs/Thyroid-cancer-guidelines-2007.pdf
17. The American Thyroid Association Guideline Taskforce (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
18. Sugitani I, Fujimoto Y (1999) Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J 46:209-216
19. Sugitani I, Kasai N, Fujimoto Y et al (2004) A novel classification system for patients with PTC: addition of the new variablesof large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139-148
20. Sugitani I, Fujimoto Y, Yamamoto N (2008) Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 143:35-42
21. Sugitani I, Fujimoto Y, Yamada K et al (2008) Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg 32:2494-2502
22. Sugitani I, Fujimoto Y (2009) Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence. Surg Today (in press)
23. Medical Professionalism Project (2002) Medical professionalism in the new millennium: a physicians' charter. Lancet 359:520-522
24. Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399-407
25. Ito Y, Miyauchi A (2007) A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab 3:240-248
26. Davies L, Gilbert Welch H (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
27. Roti E, degli Uberti EC, Bondanelli M et al (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659-673
28. Chow SM, Law SCK, Chan JKC et al (2003) Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40
29. Roti E, Rossi R, Trasforini G et al (2006) Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91:2171-2178
30. Cappelli C, Castellano M, Braga M et al (2007) Aggressiveness and outcome of papillary thyroid carcinoma versus microcarcinoma: a mono-institutional experience. J Surg Oncol 95:555-560
31. Van den Bruel A, Moreno-Reyes R, Bex M et al (2008) Is the management of thyroid nodules and differentiated thyroid cancer in accordance with recent consensus guidelines? Results of a national survey. Clin Endocrinol 68:599-604
32. Mazzaferri EL (2007) Management of low-risk differentiated thyroid cancer. Endocr Pract 5:498-512
33. Cady B (1998) Presidential address: beyond risk groups: a new look at differentiated thyroid cancer. Surgery 124:947-957
34. Pelizzo MR, Boschin LM, Toniato A et al (2006) Papillary thyroid microcarcinoma: prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 32:1144-1148
35. Rouxel A, Hejblum G, Bernier MO et al (2004) Prognostic factors associated with the survival of patients developing locoregional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 89:5362-5368
36. Ito Y, Tomoda C, Uruno T et al (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115-1121
37. Ito Y, Tomoda C, Uruno T et al (2004) Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg 28:498-501
38. Ito Y, Uruno T, Nakano K et al (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381-387
39. Cady B, Rossi R (1988) An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104:947-953
40. Hay ID, Grant CS, Taylor WF et al (1987) Ipsilateral lobectomy versus bilateral lober resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095
41. Hay ID, Bergstralh EJ, Goellner JR et al (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058
42. Ito Y, Kobayashi K, Tomoda C et al (2005) Ill-defined edge on ultrasonographic examination can be a marker of aggressive characteristic of papillary thyroid microcarcinoma. World J Surg 29:1007-1012
43. kip1 expression in papillary carcinoma of the thyroid ≤ 1 cm and their paired lymph node metastases. Cancer 110:1218-1226
44. Lee X, Gao M, Ji Y et al (2009) Analysis of differential BRAFV600E mutational status in high aggressive papillary thyroid microcarcinoma. Ann Surg Oncol 16:240-245